B&T is a global developer and manufacturer of high-performance natural ingredients for the cosmetics and personal care industry, based on olive chemistry.
The company has a significant intellectual property portfolio based on the development of successful ranges for emulsifiers, stabilizing agents, emollients and active ingredients, supplied to the domestic market in Italy and worldwide.
The next move into the naturals area
“The acquisition of B&T represent an exciting next step in HallStar’s strategic move into the naturals space,” said John Paro, HallStar Chairman, CEO and president.
“In addition to our broad portfolio of natural butters sourced globally by our BioChemica business, B&T brings HallStar a tremendous portfolio of branded products built on a strong patent portfolio, and strengthens our geographic footprint globally.”
Amongst the product offerings in the B&T portfolio are two of the company’s leading brands - Olivem and Sensolene.
Olivem and Sensolene leading brands
Olivem has been designed to combine natural ingredients with advanced science by incorporating natural olive extract with a patented technology to process the fatty acids contained in the extract.
Sensolene is a high functional dermollient classified as an active ingredient and targeted as a complex emollient due its compatibility and stability, as well as its ability to improve formulation texture.
B&T managing director Sergio Amari noted that the acquisition is likely to help accelerate growth in the personal care naturals platform based on the fact that the company produces high performance products from natural ingredients.
At the end of January this year, HallStar announced the acquisition of another small natural ingredients players BioChemica, which manufactures and supplies exotic butters and oils, including some certified organic.
BioChemica brings technical expertise in developing and marketing exotic butters, while HallStar will support BioChemica in developing new consumer-friendly products and market existing ones.
HallStar has cited market data from Kline that put the compound annual growth rate of the market from 2003 – 2009 at 14 percent, and valued natural and organic sales in the US at $3.8bn in 2009.
In an interview given by Paro to CosmeticsDesign that is posted on the site today, the HallStar CEO explains the benefits of the BioChemica acquisition, while hinting that further acquisitions would be likely in the future.